GDF11 and metabolic dysfunction-associated steatotic liver disease: found that decreased levels of GDF11 have been associated with NAFLD, increased body mass index (BMI), increased diastolic blood pressure, TG, low‐density lipoprotein (LDL), HOMA‐IR, fasting blood sugar (FBS), and two‐hour postprandial glucose (2hpp), as well as metabolic syndrome‐related morbidity in Chinese population.29